Y
Yutaka Shimada
Researcher at University of Toyama
Publications - 445
Citations - 15929
Yutaka Shimada is an academic researcher from University of Toyama. The author has contributed to research in topics: Cancer & Esophageal cancer. The author has an hindex of 58, co-authored 441 publications receiving 14980 citations. Previous affiliations of Yutaka Shimada include Kyoto University & Niigata University.
Papers
More filters
Journal ArticleDOI
Expression and function of the calcium-sensing receptor in pancreatic islets and insulinoma cells.
Izumi Komoto,Masayuki Kato,Atsushi Itami,Yutaka Shimada,Ryuichiro Doi,Ryo Hosotani,Masayuki Imamura +6 more
TL;DR: Findings suggest that the signaling pathways controlling the changes in [Ca2+]i differ between normal rat islets and human insulinoma cells.
Journal ArticleDOI
Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver.
Makoto Fujimoto,Koichi Tsuneyama,Mosaburo Kainuma,Nobuyasu Sekiya,Hirozo Goto,Yasuo Takano,Katsutoshi Terasawa,Katsutoshi Terasawa,Carlo Selmi,M. Eric Gershwin,Yutaka Shimada +10 more
TL;DR: There was a statistically significant benefit of Kampo formulas (KBG in particular) on a dietary model of NAFLD/NASH and future studies need to be directed at the mechanisms in the treatment of NASH.
Journal ArticleDOI
Polo-like kinase and survivin are esophageal tumor-specific promoters.
Fumiaki Sato,John M. Abraham,Jing Yin,Takatsugu Kan,Tetsuo Ito,Yuriko Mori,Yuriko Mori,James P. Hamilton,Zhe Jin,Yulan Cheng,Bogdan C. Paun,Agnes T. Berki,Suna Wang,Yutaka Shimada,Stephen J. Meltzer +14 more
TL;DR: The promoters of PLK and survivin could be useful tools for developing EC-specific gene therapy vectors.
Journal ArticleDOI
Endoscopic versus conventional open thyroid lobectomy for benign thyroid nodules: a prospective study.
TL;DR: Compared with conventional surgery, endoscopic thyroidectomy for benign thyroid nodules was associated with less blood loss, although blood loss was minimal for both procedures, and there were no practical differences in technical ability to perform.
Journal ArticleDOI
Growth inhibition through activation of peroxisome proliferator-activated receptor γ in human oesophageal squamous cell carcinoma
Yosuke Hashimoto,Yutaka Shimada,Atsushi Itami,Tetsuo Ito,Jun Ichiro Kawamura,Atsushi Kawabe,Junichi Kaganoi,Masato Maeda,Go Watanabe,Masayuki Imamura +9 more
TL;DR: Results suggest that the PPARgamma/RXRalpha heterodimer may be a new therapeutic target for oesophageal squamous cell carcinoma.